-
1.发明公开Botulinum toxin dosage regimen for depression 审中-公开DosierschemafürBotulinumtoxin zur Vorbeugung von chronischerMigräne
公开(公告)号：EP2735313A1
公开(公告)日：2014-05-28
申请号：EP14156327.0
申请日：2011-03-29
申请人： Allergan, Inc.
CPC分类号： A61K38/4893 , A61K9/0019 , A61K35/74 , C07K14/33 , C12Y304/24069
摘要： Disorders such as depression can be treated by administration of a botulinum toxin to a patient suffering therefrom. A combined a fixed site/fixed dose and an optional follow the pain variable dosage and injection site paradigm is disclosed for optimizing clinical effectiveness of botulinum toxin administration for patients.
摘要翻译： 诸如抑郁症等疾病可以通过向患有这种药物的患者施用肉毒杆菌毒素来治疗。 公开了固定部位/固定剂量和可选的疼痛变量剂量和注射部位范例的组合，以优化患者的肉毒杆菌毒素给药的临床有效性。
-
2.发明授权Medicaments comprising botulinum toxin for use in treating exacerbation of headache in medication overusers 有权含肉毒杆菌毒素，其用于头痛恶化过度使用止痛药的治疗药
公开(公告)号：EP2433643B1
公开(公告)日：2015-12-02
申请号：EP11194257.9
申请日：2005-02-15
申请人： ALLERGAN, INC.
CPC分类号： A61K38/4893 , A61K9/0019 , C12Y304/24069
摘要： The present invention relates to a medicament for increasing the effectiveness of a triptan medication to treat a headache comprising a triptan and a botulinum toxin.
摘要翻译： 本发明涉及一种药物用于增加曲坦药物的有效性来治疗头痛，包括曲坦和肉毒毒素。
-
公开(公告)号：EP3311831A1
公开(公告)日：2018-04-25
申请号：EP17189376.1
申请日：2011-03-29
申请人： ALLERGAN, INC.
CPC分类号： A61K38/4893 , A61K9/0019 , A61K35/74 , C07K14/33 , C12Y304/24069
摘要： Disorders such as headaches can be treated by administration of a botulinum toxin to a patient suffering therefrom, such as a migraine headache. A combined a fixed site/fixed dose and an optional follow the pain variable dosage and injection site paradigm is disclosed for optimizing clinical effectiveness of botulinum toxin administration for patients suffering from chronic migraine. The injection schedule requires a minimum dose of 155 U using a fixed-site, fixed-dose injection regimen into 31-39 sites across 7 head/nech muscles, namely the frontalis, corrugator, procerus, occipitalis, temporalis, trapezius and cervical paraspinal muscles.
摘要翻译： 诸如头痛之类的疾病可以通过向患有偏头痛的患者施用肉毒杆菌毒素来治疗。 公开了一种固定部位/固定剂量和任选的组合，其遵循疼痛可变剂量和注射部位范例，用于优化患有慢性偏头痛的患者的肉毒杆菌毒素施用的临床效果。 注射时间表需要使用固定部位固定剂量注射方案的最小剂量为155U，穿过7头/内侧肌肉的31-39个部位，即额骨，皱眉器，前掌，枕骨，颞骨，斜方肌和颈椎旁肌 。
-
公开(公告)号：EP4140499A1
公开(公告)日：2023-03-01
申请号：EP22184142.2
申请日：2011-03-29
申请人： ALLERGAN, INC.
摘要： Disorders such as headaches can be treated by administration of a botulinum toxin to a patient suffering therefrom, such as a migraine headache. A combined a fixed site/fixed dose and an optional follow the pain variable dosage and injection site paradigm is disclosed for optimizing clinical effectiveness of botulinum toxin administration for patients suffering from chronic migraine. The injection schedule requires a minimum dose of 155 U using a fixed-site, fixed-dose injection regimen into 31-39 sites across 7 head/nech muscles, namely the frontalis, corrugator, procerus, occipitalis, temporalis, trapezius and cervical paraspinal muscles.
-
5.发明公开Medicaments and methods for treating headache in triptan overusers 审中-公开药物和患者过度2,2,3-三甲基丁烷定制头痛医头的方法
公开(公告)号：EP2752197A1
公开(公告)日：2014-07-09
申请号：EP14163033.5
申请日：2005-02-15
申请人： Allergan, Inc.
摘要： Use of a botulinum toxin to treat a headache in a triptan medication overuse patient.
摘要翻译： 肉毒毒素的使用在曲坦类药物过度使用患者治疗头痛。
-
-
7.发明公开Medicaments comprising triptan and botulinum toxin for use in treating headache 有权含肉毒杆菌毒素，其用于头痛恶化过度使用止痛药的治疗药
公开(公告)号：EP2433643A1
公开(公告)日：2012-03-28
申请号：EP11194257.9
申请日：2005-02-15
申请人： Allergan, Inc.
CPC分类号： A61K38/4893 , A61K9/0019 , C12Y304/24069
摘要： The present invention relates to a medicament for increasing the effectiveness of a triptan medication to treat a headache comprising a triptan and a botulinum toxin.
-
-
-
-
-
-
搜索结果
7 条记录 (耗时 0.017 秒)
